Israel Englander Moderna, Inc. Put Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $53.8 Million - $88.5 Million	531,200 Added 737.78%	603,200 $71.6 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $384,165 - $519,480	4,500 Added 6.67%	72,000 $7.67 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $7.3 Million - $11 Million	-105,000 Reduced 60.87%	67,500 $6.71 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $1.9 Million - $2.57 Million	16,000 Added 10.22%	172,500 $21 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $34.3 Million - $49.9 Million	-253,100 Reduced 61.79%	156,500 $24 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $4.83 Million - $8.57 Million	-40,800 Reduced 9.06%	409,600 $73.6 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $25.2 Million - $41.5 Million	-213,700 Reduced 32.18%	450,400 $53.3 Million

1,027

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $20.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.